Member Info for Davand

Penny will have done the DD on ygen and been satisfied of their financial position going forward. MHC will need the money they have to launch all these products for starters. There is no guarantee they will sell well atm either. A bigger company could buy ygen and cut out the fat and deadwood and be into profit. MHC are too small to take them over .

I can't see MHC going anywhere near ygen if they were going t its up anytime soon. They must have done their homework and due diligence on ygen.

There's plenty who will take it over if they go into administration. I don't think Penny would use ygen if the writing was on the wall. Boots would need assurances too.

What is possible is some sort of partnership or tie up/amalgamation.

Jam, behave! How you going to pay for it? How much do you think it will cost? Biggest shareholders need 2.5p breakeven.

Yes, but not everyone sells them in Boots stores.

Wonder if they are any closer to start selling some of those Ambry products we were told about?

Hopefully rolled out to more of their 2000 + stores if things go well.

Hopefully the start of many Stas.

MHC didn't show any figures so I didn't expect ygen to.

Every little helps! Anyway, it could well be a nice little earner.

Had hoped/expected this might happen. Return the favour for the covid tests they had off ygen. Good news at last.

Big players didn't get there by paying over the odds for anything. They won't for Ygen either. Why on earth does anyone think they would pay 10x current mcap?

GLT, lame reason that they can't rns because of a re structure. They have to rns anything material regardless of what else is happening . It might be some other reason, but not for re structure, imo .

MBO at 0.005p or thereabouts?

Hey Morse, high teens will be great. But I'm not greedy, so 10p will do me..lol.

A couple more vacancies today. Two Logistics roles, so getting busy it seems . Should bode well.

When did this happen? Who was it? Why was it not a rns?

"In the UK, the acquisition of a new customer partner with a broad network of clinics has been a growth driver".

Being manipulated deliberately for a lowball. Management not reporting new contract wins and nobody seems to know who they acquired with their labs which is delivering growth. Probably many more reportable events, but that's not the agenda. They don't want any good news out there , because it might spike the sp .

At least they are planning for at least another 6 months. Lol

Smudge, it'll take a bit more than a few exciting marketing and sales ideas to make any difference unfortunately.